CervoMed Inc. (CRVO)
Pharmaceutical Preparations
Latest Price
$2.58
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.15
P/B Ratio
2.25
Valuation metrics
adjust assumptions →EPS: $2038891.00
Book value / share: $1.97
Formula: √(22.5 × EPS × BVPS)
Graham Number
$9,505.22
+368320% upside
EPS: $2038891.00
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$30,583,365.00
+1185401644% upside
Institutional Ownership
19.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MORGAN STANLEY | 739.9K | $2.0M | 7.99% | +265.4K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 316.2K | $1.0M | 3.42% | -- | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 208.9K | -- | 2.26% | +148.6K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 74.4K | -- | 0.80% | +8.5K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 63.9K | -- | 0.69% | -- | 2026-03-31 |
| BlackRock, Inc. | 51.7K | -- | 0.56% | +2.5K | 2026-03-31 |
| XTX Topco Ltd | 38.5K | -- | 0.42% | +28.2K | 2026-03-31 |
| CITIZENS FINANCIAL GROUP INC/RI | 37.5K | -- | 0.40% | -- | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 36.2K | -- | 0.39% | -- | 2026-03-31 |
| NORTHERN TRUST CORP | 30.0K | -- | 0.32% | -605 | 2026-03-31 |